RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.
Metrics to compare | RCAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRCARPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −2.9x | −0.6x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 1.4x | 2.6x | |
Price / LTM Sales | 0.0x | 8.6x | 3.3x | |
Upside (Analyst Target) | 0.0% | 200.7% | 39.0% | |
Fair Value Upside | Unlock | −0.6% | 4.9% | Unlock |